Cargando…
Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer
Breast cancer (BC) is a highly heterogeneous disease. The treatment of BC is complicated owing to intratumoral complexity. Tissue biopsy and immunohistochemistry are the current gold standard techniques to guide breast cancer therapy; however, these techniques do not assess tumoral molecular heterog...
Autores principales: | de Freitas, Ana Julia Aguiar, Causin, Rhafaela Lima, Varuzza, Muriele Bertagna, Calfa, Stéphanie, Hidalgo Filho, Cassio Murilo Trovo, Komoto, Tatiana Takahasi, Souza, Cristiano de Pádua, Marques, Márcia Maria Chiquitelli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456236/ https://www.ncbi.nlm.nih.gov/pubmed/36077348 http://dx.doi.org/10.3390/ijms23179952 |
Ejemplares similares
-
Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review
por: de Freitas, Ana Julia Aguiar, et al.
Publicado: (2021) -
A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression
por: Causin, Rhafaela Lima, et al.
Publicado: (2021) -
Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial
por: Freitas, Ana Julia Aguiar, et al.
Publicado: (2023) -
MicroRNA‑130a‑3p inhibition suppresses cervical cancer cell progression
por: Causin, Rhafaela Lima, et al.
Publicado: (2023) -
Exploring the Therapeutic Potential of trans-Chalcone: Modulation of MicroRNAs Linked to Breast Cancer Progression in MCF-7 Cells
por: Komoto, Tatiana Takahasi, et al.
Publicado: (2023)